Corporate Governance

Pinduoduo and Full Truck Alliance continue to list in the U.S.; Chinese companies raised far more money in Europe than U.S. in 2022; and official reports show promising improvements to China's IP systems

Jianwei Jerry Fang, Runyang Liu and Dianmeng Zhu of Zhong Lun Law Firm discuss the year's major legislative and judicial developments in civil and commercial dispute resolution in China.

Geoffrey Chan, Sophie Xue, and Nicholas Poon of Skadden, Arps, Slate, Meagher & Flom examine how the Hong Kong Limited Partnership Fund, which serves as a cost and tax efficient vehicle for private equity transactions, could become a popular alternative to traditional offshore fund structures for PE investments and fundraising in Greater China

New social credit draft law raises concerns for foreign companies; CSRC lifts ban on property M&A and refinancing; and U.K. government unwinds a completed transaction for the first time.

Compliance Director at one of China's largest insurance companies speaks about current issues and future developments surrounding the country's insurance industry.

PCAOB and Beijing reach audit agreement to prevent mass delisting; U.S.-China merger abandoned following U.S. antitrust investigation; new compliance rules for wealth management companies

CBIRC enhances life insurance disclosure requirements of insurance companies

CSRC sets forth disclosure requirements for listed pharma companies.

A U.S. company acquiring a Chinese company will face a multitude of regulatory restrictions and requirements. How can the U.S. acquirer manage the risk of the deal being blocked or unwound for non-compliance?